{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Yeast Voriconazole",
        "VITEK 2 AST-YS Voriconazole"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K232967",
    "Predicate Device Reference 510(k) Number(s)": [
        "K213241"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGZ",
        "LRG",
        "LTT",
        "LTW",
        "LON"
    ],
    "Summary Letter Date": "May 7, 2024",
    "Summary Letter Received Date": "May 7, 2024",
    "Submission Date": "May 7, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "mycology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Voriconazole"
    ],
    "Specimen Type(s)": [
        "Yeast isolate"
    ],
    "Specimen Container(s)": [
        "Saline suspension"
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK 2 System",
        "VITEK 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated microdilution",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Methodologies": [
        "Microdilution",
        "Automated susceptibility testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Panel",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-Yeast Voriconazole for antifungal susceptibility testing of Candida species using automated microdilution.",
    "Indications for Use Summary": "Designed for antifungal susceptibility testing of Candida species as a laboratory aid in the determination of in vitro susceptibility to antifungal agents using VITEK 2 and VITEK 2 Compact Systems.",
    "fda_folder": "Microbiology"
}